ME/CFS patients generally showed greater variability in the fold changes of several proteins compared with controls, such as MAGED2, SNCA, GP1BA, and CNPY2. The gene discussed is MAGED2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.